Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $48.00 price target on the stock.
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
What Makes Insmed (INSM) a Lucrative Investment? [Yahoo! Finance]
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)